Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Petros Pharmaceuticals's operating margin for the twelve months ending Dec 31, 2024 was -90.5%. For fiscal 2024 it was -90.5%, against -233.9% the year before. The highest annual figure on record is -90.5% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -90.5% | +143.4 |
| FY2023 | Dec 31, 2023 | -233.9% | +98.5 |
| FY2022 | Dec 31, 2022 | -332.4% | −101.3 |
| FY2021 | Dec 31, 2021 | -231.1% | −50.3 |
| FY2020 | Dec 31, 2020 | -180.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | -79.6% | +207.4 |
| Q3 FY2024 | Sep 30, 2024 | -76.0% | +47.6 |
| Q2 FY2024 | Jun 30, 2024 | -94.9% | −42.9 |
| Q1 FY2024 | Mar 31, 2024 | -108.2% | +405.6 |
| Q3 FY2023 | Sep 30, 2023 | -287.0% | −247.3 |
| Q2 FY2023 | Jun 30, 2023 | -123.5% | −104.0 |
| Q1 FY2023 | Mar 31, 2023 | -52.0% | +122.2 |
| Q4 FY2022 | Dec 31, 2022 | -513.9% | −459.9 |
| Q2 FY2022 | Jun 30, 2022 | -39.7% | +107.7 |
| Q1 FY2022 | Mar 31, 2022 | -19.5% | +47.9 |
| Q2 FY2021 | Jun 30, 2021 | -174.2% | +191.2 |
| Q1 FY2021 | Mar 31, 2021 | -53.9% | +259.1 |
| Q4 FY2020 | Dec 31, 2020 | -147.4% | – |
| Q3 FY2020 | Sep 30, 2020 | -67.4% | – |
| Q2 FY2020 | Jun 30, 2020 | -365.3% | – |
| Q1 FY2020 | Mar 31, 2020 | -313.0% | – |
See a number that looks wrong?